AMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE

Core Points - Amgen will present at the 35th Annual Oppenheimer Healthcare Life Sciences Conference on February 12, 2025, at 11:20 a.m. ET [1] - The presentation will be led by Narimon Honarpour, senior vice president of global development at Amgen [1] - The webcast will be available for media, investors, and the general public, and will be archived for at least 90 days [2] Company Overview - Amgen is a biotechnology company that discovers, develops, manufactures, and delivers innovative medicines for various diseases [3] - The company has a strong pipeline focused on treating cancer, heart disease, osteoporosis, inflammatory diseases, and rare diseases [3] - Amgen has been recognized as one of the "World's Most Innovative Companies" and "America's Best Large Employers" in 2024 [4] - It is part of the Dow Jones Industrial Average and the Nasdaq-100 Index, highlighting its market significance [4]